Summary
To investigate the possibility that an abnormality of the entero-insular axis is responsible for the hyperinsulinaemia of obesity, serum immunoreactive gastric inhibitory polypeptide (IR-GIP) and insulin (IRI) were measured after the ingestion of a liquid mixed test meal, glucose or fat, in normal weight and obese subjects. The latter were divided into a group with normal oral glucose tolerance (nOGT) and a group with pathological glucose tolerance (pOGT). Fasting levels of IR-GIP were significantly elevated in the obese group with pOGT. After the mixed meal the overweight subjects showed a significantly greater response of IR-GIP than the controls, with highest levels in the pOGT group. Simultaneously, the IRI response was significantly greater in the obese subjects than in the controls. The increases of IR-GIP and IRI after an oral load of 100 g glucose were normal in the obese subjects, but showed a significantly greater integrated response in the obese patients with pOGT. The ingestion of 100 g fat induced no IRI release but a significantly greater release of IR-GIP in the obese subjects, irrespective of their glucose tolerance. It is concluded that fat is a stronger releaser of IR-GIP than glucose. The effect of a combined load of glucose (30 g) and fat (100 g) was also compared in obese and normal weight subjects with the effect of either alone. Fat but not glucose released significantly more IR-GIP in obese subjects. In normal weight controls, but not in obese subjects, the IR-GIP release after fat plus glucose became significantly smaller than after fat alone. Since only the combined ingestion of glucose and fat and not fat alone releases insulin it is suggested that endogenous insulin inhibits GIP release and that this feedback control between insulin and GIP is defective in patients with obesity.
Article PDF
Similar content being viewed by others
References
Karam, J.H., Grodsky, G.M., Forsham, P.H.: Excessive insulin response to glucose in obese subjects as measured by immunochemical assay. Diabetes 12, 197–205 (1963)
Yalow, R.S., Glick, S.M., Roth, J., Berson, S.A.: Plasma insulin and growth hormone levels in obesity and diabetes. Ann. N. Y. Acad. Sci. 131, 357–373 (1965)
Bagdade, J.D., Bierman, E.L., Porte, D.: The significance of basal insulin in the evaluation of the insulin response to glucose in diabetic and non diabetic subjects. J. Clin. Invest. 46, 1549–1557 (1967)
Kreisberg, R.A., Boshell, B.R., Di Placido, J., Roddam, R.F.: Insulin secretion in obesity. N. Engl. J. Med. 276, 314–319 (1967)
Rabinowitz, D., Zierler, K.L.: Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinism. J. Clin. Invest. 41, 2173–2182 (1962)
Perley, M.J., Kipnis, D.M.: Plasma insulin response to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects. Diabetes 15, 867–874 (1966)
Colwell, J.A., Lein, A.: Diminished insulin response to hyperglycemia in prediabetes and diabetes. Diabetes 16, 560–565 (1967)
De Meyts, P., Bianco, A.R., Roth, J.: Site-site interactions among insulin receptors. Characterization of the negative cooperativity. J. Biol. Chem. 251, 1877–1888 (1976)
Roth, J., Kahn, R., Lesniak, M.A., Gorden, P., De Meyts, P., Megyesi, K., Neville, Jr., D.M., Gavin, J.R., Soll, A.H., Freychet, P., Goldfine, I.D., Bar, R.S., Archer, J.A.: Receptors for insulin, NSILA-s, and growth hormone: application to disease states in man. Recent Prog. Horm. Res. 31, 95–139 (1975)
Bar, R.S., Gorden, P., Roth, J., Kahn, R., De Meyts, P.: Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients. Effects of starvation, refeeding, and dieting. J. Clin. Invest. 58, 1123–1135 (1976)
Creutzfeldt, W.: Insulin-releasing factors of the gastrointestinal mucosa (incretin). Gastroenterology 67, 748–750 (1974)
Köbberling, J., Creutzfeldt, W.: Comparison of different methods for the evaluation of the oral glucose tolerance test. Diabetes 19, 870–877 (19 (1970)
Brown, J.C., Dryburgh, J.R., Ross, S.A., Dupré, J.: Identification and actions of gastric inhibitory polypeptide. Recent Prog. Horm. Res. 31, 487–532 (1975)
Cataland, S., Crockett, S.E., Brown, J.C., Mazzaferri, E.L.: Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man. J. Clin. Endocrinol. Metab. 39, 223–228 (1974)
Cleator, J.G.M., Gourlay, R.H.: Release of immunoreactive gastric inhibitory polypeptide (IR-GIP) by oral ingestion of food substances. Am. J. Surg. 130, 128–135 (1975)
Falko, J.M., Crockett, S.E., Cataland, S., Mazzaferri, E.L.: Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man. J. Clin. Endocrinol. Metab. 41, 260–265 (1975)
Pederson, R.A., Schubert, H.E., Brown, J.C.: Gastric inhibitory polypeptide. Its physiologic release and insulinotropic action in the dog. Diabetes 24, 1050–1056 (1975)
Dupré, J., Ross, S.A., Watson, D., Brown, J.C.: Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J. Clin. Endocrinol. Metab. 37, 826–828 (1973)
Schauder, P., Brown, J.C., Frerichs, H., Creutzfeldt, W.: Gastric inhibitory polypeptide: effect on glucose-induced insulin release from isolated rat pancreatic islets in vitro. Diabetologia 11, 483–484 (1975)
Pederson, R.A., Brown, J.C.: The insulinotropic action of gastric inhibitory polypeptide in the perfused isolated rat pancreas. Endocrinology 99, 780–785 (1976)
Ebert, R., Willms, B., Brown, J.C., Creutzfeldt, W.: Serum gastric inhibitory polypeptide (GIP) levels in obese subjects and after weight reduction. Eur. J. Clin. Invest. 6, 327 (1976)
Documenta Geigy Scientific Tables: 6th ed., p. 624. Manchester: Geigy 1962
Creutzfeldt, W., Ebert, R., Arnold, R., Frerichs, H., Brown, J.C.: Gastric inhibitory polypeptide (GIP), gastrin, and insulin: response to test meal in coeliac disease and after duodenopancreatectomy. Diabetologia 12, 279–286 (1976)
Melani, F., Ditschuneit, H., Bartelt, K.M., Friedrich, H., Pfeiffer, E.F.: Über die radioimmunologische Bestimmung von Insulin im Blut. Klin. Wochenschr. 43, 1000–1007 (1965)
Kuzio, M., Dryburgh, J.R., Malloy, K.M., Brown, J.C.: Radioimmunoassay for gastric inhibitory polypeptide. Gastroenterology 66, 357–364 (1974)
Brown, J.C., Mutt, V., Pederson, R.A.: Further purification of a polypeptide demonstrating enterogastrone activity. J. Physiol. (Lond.) 209, 57–64 (1970)
Stern, D.H., Walsh, J.H.: Gastrin release in postoperative ulcer patients: evidence for release of duodenal gastrin. Gastroenterology 64, 363–369 (1973)
Pelkonen, R., Nikkilä, E.A., Taskinen, M.R., Mietinnen, T.: Plasma insulin (IRI) response to small doses of intravenous glucose: influence of obesity and fasting. Scand. J. Clin. Lab. Invest. 21 (Suppl. 101), 25 (1968)
Jacot, J.P., Zuppinger, K.A., Joss, E.E., Donath, A.: Evidence for two types of juvenile obesity on the basis of body composition and insulin release following small doses of glucose. Klin. Wochenschr. 51, 1109–1114 (1973)
Crockett, S.E., Mazzaferri, E.L., Cataland, S.: Gastric inhibitory polypeptide in maturity-onset diabetes mellitus. Diabetes 25, 931–935 (1976)
Cataland, S.: Discussion to Brown et al. Recent Prog. Horm. Res. 31, 526–528 (1975)
Bloom, S.R.: GIP in diabetes. Diabetologia 11, 334 (1975)
Böttger, I., Dobbs, R.E., Faloona, G.R., Unger, R.H.: The effects of triglyceride absorption upon glucagon, insulin and gut glucagon-like immunoreactivity. J. Clin. Invest. 52, 2532–2539 (1973)
Crockett, S.E., Cataland, S., Falko, J.M., Mazzaferri, E.L.: The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects. J. Clin. Endocrinol. Metab. 42, 1098–1103 (1976
Ogilvie, R.: Sugar tolerance in obese subjects: a review of 65 cases. Q. J. Med. 28, 345–358 (1935)
Thomas, F.B., Mazzaferri, E., Crockett, S.E., Mekhjiam, H.S., Gruemer, H.D., Cataland, S.: Stimulation of secretion of gastric inhibitory polypeptide and insulin by intraduodenal amino acid perfusion. Gastroenterology 70, 523–527 (1976)
Creutzfeldt, W., Ebert, R.: Release of gastric inhibitory polypeptide (GIP) to a test meal under normal and pathological conditions in man. Proceedings of the 9th Congress of the International Diabetes Federation, New Delhi 1976. Amsterdam: Excerpta Medica (in press)
Ebert, R., Frerichs, H., Creutzfeldt, W.: Serum gastric inhibitory polypeptide (GIP) response in patients with maturity onset diabetes and in juvenile diabetics. Diabetologia 12, 388 (1976)
Polak, J.M., Pearse, A.G.E., Grimelius, L., Marks, V.: Gastrointestinal apudosis in obese hyperglycemic mice. Virchows Archiv [Cell Pathol.] 19, 135–150 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Creutzfeldt, W., Ebert, R., Willms, B. et al. Gastric inhibitory polypeptide (GIP) and insulin in obesity: Increased response to stimulation and defective feedback control of serum levels. Diabetologia 14, 15–24 (1978). https://doi.org/10.1007/BF00429703
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00429703